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ABSTRACT With a view toward possible new insights into viral fusion mechanisms, we have investigated the HIV-1 gp41
fusion peptide in a monomolecular film of the biomembrane lipid palmitoyloleoylphosphatidylcholine. Its surface activity at an
air/water interface was measured under equilibrium conditions, using the conventional Langmuir trough technique. Through
a novel thermodynamic analysis, the partial molecular area of the peptide in the lipid moiety could be determined as a function
of the lateral pressure and the interfacial peptide/lipid ratio. This indicates an orientation of the peptide backbone parallel to
the lipid hydrocarbon tails. The molecular area decreases significantly upon monolayer compression, suggesting a confor-
mational transition from a somewhat compact configuration to a more extended, presumably -strand structure when a lipid
packing density is approached that is generally believed to mimic the physical state of a biological membrane. Up to a lateral
pressure of 15 mN/m, practically all peptide inserts into the lipid monolayer. At higher compression a distinct partitioning
into the aqueous subphase is observed. Under these conditions the data also reflect a strong aggregation of the lipid-
associated peptide. Beyond a critical peptide/lipid ratio, the peptide’s area requirement was found to become substantially
enhanced, possibly because of the formation of water-filled pores.
INTRODUCTION
Entrance of an enveloped animal virus into a host cell is
mediated by specific fusion proteins spanning the viral
membrane (Marsh and Helenius, 1989). The molecular
mechanism of such a process has so far not been satisfac-
torily elucidated (Stegmann, 1994). In particular, the issue
of the possible formation of a proteinaceous pore in the
target membrane has led to controversial discussions (Sie-
gel, 1993; Colotto et al., 1996). Experimental evidence of
relevant structures by means of patch-clamp studies was
reported for the hemagglutinin of influenza virus (Spruce et
al., 1989; Tse et al., 1993). More recently this has been
confirmed by a fluorescence assay (Blumenthal et al.,
1996). There is as yet no corresponding information on the
human immunodeficiency virus (HIV). Nevertheless, the
N-terminal sequence of 23 amino acid residues of the gp41
protein in the viral envelope has been identified as a puta-
tive fusion peptide (Gallaher, 1987). Synthesized samples of
it are poorly soluble in water but exhibit a pronounced
surface activity at the air/water interface (Rafalski et al.,
1990). If bound, this peptide spans only half of a lipid
bilayer (Brasseur et al., 1988; Gordon et al., 1992). Thus
fundamental structural and thermodynamic data regarding
the peptide’s interaction with a lipid monolayer may be
acquired with the conventional Langmuir trough technique.
This approach takes advantage of measurement of the
surface pressure exerted on the barriers that confine a mono-
molecular film of amphiphilic material. The results may be
analyzed in terms of the interfacial molecular areas and
mutual energetic interactions. In recent decades special at-
tention has been directed toward so-called insoluble mono-
layers (Gaines, 1966). These are presumed to lack any
appreciable desorption into the aqueous subphase, so that
the interfacial molecular area could be readily calculated
from the trough area and the amount of added surfactant.
Such a premise has been considered for biological lipids in
particular. Their packing density at surface pressures around
30 mN/m concurs with that of a cell membrane (Marsh,
1996a). Accordingly, a compressed lipid monolayer can be
regarded as a basic model for investigating the effect of
biomembrane active agents, particularly peptides or pro-
teins that are soluble to some extent in the aqueous
environment.
Naturally, for a reliable quantitative analysis of relevant
surface activity data, the actual partitioning of the added
material between the interfacial and bulk volume phases
must be known. Because in such a case only quantities on
the order of nanomoles can be accommodated in the surface
area of an ordinary Langmuir trough, even appreciable
desorption gives rise to only nanomolarity concentrations in
the subphase, which would easily escape direct detection.
We have therefore endeavored to solve the problem by
means of a novel procedure for collecting and evaluating
data derived from measurements of surface pressure versus
trough area. Our approach was first applied to the present
fusion peptide on a clean air/water interface (Schwarz and
Taylor, 1995). In these experiments with a single surfactant
component, pressure/area isotherms had been recorded un-
der equilibrium conditions for a number of different total
amounts of the peptide. Because of the law of mass conser-
vation, a plot of these amounts versus the respective film
area at a given surface pressure results in a straight line
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whose slope is equal to the effective surface concentration,
whereas the intercept on the ordinate reflects the amount
being dissolved in the subphase. The method has been
further applied to the same fusion peptide under a change of
pH (Taylor and Schwarz, 1997), to the bee venom factor
melittin (Wackerbauer et al., 1996), and to the lipid palmi-
toyloleoylphosphatidylcholine (POPC) (Schwarz et al.,
1996).
When some peptide is added to a lipid film, a possible
insertion is readily detected by the inherent increase in
monolayer area at constant pressure. However, to calculate
the area per inserted peptide molecule, its interfacial molar
fraction must be determined. To this end we have extended
our previous mass conservation approach to a mixture of
two surfactant components. Preliminary accounts have been
given elsewhere (Schwarz and Taylor, 1997a,b). Here we
present an improved and more detailed analysis. It provides
highly interesting quantitative information on structural and
thermodynamic features of the viral fusion peptide under
consideration upon its insertion into a membrane mimicking
lipid film. Our approach is regarded as an alternative ap-
proach to the study of molecular properties of peptide-lipid
interactions in addition to possible other methods, such as
infrared spectroscopy by means of reflection-absorption at
the air/water interface (Flach et al., 1996) or internal reflec-
tance in supported monolayers (Axelsen et al., 1995).
THEORETICAL
The present line of conducting and exploiting experiments
may be generally applied to any sparingly soluble two-
component surfactant system. In particular, we consider a
practically insoluble monolayer of a first surfactant to which
another surfactant is added that can possibly partition be-
tween the interfacial and subphase domains. Mass conser-
vation of the second surfactant accordingly implies
n2
o r  n1 n2
s (1)
where n°2, n2
s stand for the total and subphase amounts,
respectively; n1 is the amount of the insoluble surfactant;
and r  n2/n1 denotes the interfacial mixing ratio. To make
full use of that rather trivial relation, we shall establish
experimental conditions resulting in different pairs n°2, n1
but constant values of r and n2
s. Then a plot of n°2 versus n1
must be a straight line whose slope and ordinate intercept
are equal to r and n2
s, respectively. Provided that a parti-
tioning equilibrium exists, the conditions to be observed are
invariable values of both the surface pressure, , and of
A*  A/n1, which is the monolayer area (A) per amount of
the first surfactant (i.e., the reciprocal of its surface concen-
tration). This assertion can be rigorously deduced on the
basis of thermodynamic principles, as will be briefly out-
lined in the following. For a more detailed argumentation,
we refer to the Appendix.
A monomolecular film at the air/water interface defines a
two-dimensional phase (). When kept at equilibrium, any
of its thermodynamic properties will be a function of only
four independent variables, which may, in addition to A, be
chosen as the amounts of the three independent material
components, i.e., no (interfacial water), n1, and n2, respec-
tively. The variables T (temperature) and p (external pres-
sure) are assumed to be constant and will therefore be
ignored here. In particular, changes in the interfacial Gibbs
free energy may thus be expressed in terms of its total
differential:
dG  odno1dn12dn2 dA (2)
involving the respective interfacial chemical potentials i
(i  0, 1, 2) and the surface tension .
If the interface has also established a thermodynamic
equilibrium with its three-dimensional subphase (s), indi-
vidual chemical potentials of the various components must
have assumed the same values in both phases. Therefore, o
has to be equal to the chemical potential of the bulk aqueous
solvent, which remains constant under our conditions (be-
cause the soluble surfactant is supposed to enter the sub-
phase in only very small amounts). Taking into account the
identity of second derivatives of G irrespective of the order
of differentiation, it follows from Eq. 2 that 1, 2 and  
o-, respectively (where o applies to the surfactant-free
solvent) do not depend on no. Furthermore, we note that
these intensive functions of state depend only on ratios of
the remaining variables n1, n2, and A. Thus we can generally
establish the functional relationship
1, 2,  fr, A* (3a)
or alternatively,
1, 2, r f, A* (3b)
by virtue of exchanging independent variables (i.e., func-
tional inversion). In other words, the chemical potentials as
well as the interfacial mixing ratio are determined solely by
 and A*. The subphase concentration, c2, another intensive
variable of the system, is also subject to such a relationship.
We can simply infer this from the condition of a partitioning
equilibrium, namely,
2, A*2
 RT  ln c2 (4)
with 2
 standing for the conventional standard chemical
potential in the subphase (and taking c2 to be small enough
to ignore nonideal interactions). Invariable values of  and
A* must accordingly keep r and c2 definitely fixed. A
constant bulk volume, V, will then also fix n2
s ( V  c2).
This completes the conditions for a linear mass conservation
plot according to Eq. 1.
By means of functional inversion, it is generally optional
to choose, instead of , A*, any other appropriate pair of
intensive parameters as independent variables that deter-
mine the overall thermodynamic state of the system. This
conclusion remains uncontested, even if the given three
independent components are involved in additional specific
equilibria (leading to, e.g., structural or aggregational
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changes). The respective mass action and conservation laws
will always ensure that no further independent variables are
needed.
In this context we introduce the partial molar areas as
functions of  and r, namely,
Ai, r 	A/	ninj, j
 i i, j 1 or 2 (5a)
(which may be promptly converted to the respective partial
areas per molecule). A change in film area at constant  and
fixed mixing ratio (dA  A1dn1  A2dn2) can easily be
integrated, resulting in the so-called “additivity rule”:
A n1  A1 n2  A2 (5b)
which is actually a rigorous relation based on first principles.
MATERIALS and METHODS
Substances
The peptide comprises the N-terminal 23-residue sequence of the gp41
fusion protein derived from the HIV-1 strain LAV1a, namely AVGI-
GALFLGFLGAAGSTMGARS (Rafalski et al., 1990). It was self-synthe-
sized, dissolved before use in dimethyl sulfoxide (DMSO) (from Fluka,
Buchs, Switzerland), and quantified by frequently repeated amino acid
analysis to specify the concentration of stock solutions as described in full
detail previously (Schwarz and Taylor, 1995). There we also specified the
McIlvain buffer used in this study. The lipid 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC), dissolved in CHCl3, was obtained from
Avanti Polar Lipids (Alabaster, AL) and diluted with more CHCl3 (Merck,
Darmstadt, Germany). Stock solutions have repeatedly been checked for
their actual concentrations by means of phosphate analysis (Bo¨ttcher et al.,
1961). We have so confirmed the lipid’s area per molecule of 78 Å2 at 25
mN/m, as determined previously (Schwarz et al., 1996). This value was
used to calculate the lipid content in a given monolayer.
Instrumentation
The measurements have been carried out with a Langmuir round trough
manufactured by Mayer Feintechnik (Go¨ttingen, Germany) according to
the method of Fromherz (1975). It consists of eight compartments, each
with an interfacial area of 45 cm2. We have combined three of them for our
experiments. Two Teflon-made barriers in the center of the trough could be
moved to close in the monolayer area at a speed of 5 cm2/min (correspond-
ing to 5–17 Å2/min of mean peptide/lipid molecular area, depending on the
amount of interfacial surfactant). The effective trough area was calculated
geometrically and picked up by an electronic device (monofilmmeter),
together with the respective surface pressure as measured by a Wilhelmy
platelet (made of filter paper no. 1; Whatman International, Maidstone,
England). Calibration of both parameters has always been performed
before each measurement series. We note that the Wilhelmy plate of the
film balance gives rise to a monolayer area increment that had so far been
generally overlooked (Welzel et al., 1998). This effect can be corrected for
by an effective surface increment (depending on the plate size) added to the
geometrical trough area. It results in a minor parallel shift toward larger
interfacial areas, as far as the mass conservation plots are concerned. Thus
the molecular areas (derived from the slope) remain unaffected. Only the
subphase desorption (derived from the ordinate intercept) may prove to be
somewhat reduced. In the special case of POPC, a reevaluation of our
previous data (Schwarz et al., 1996) revealed that this lipid actually forms
a practically insoluble monolayer. In the present case we determined an
effective surface area increment of 2.9 cm2. Thus the molecular area of the
pure liquid has been computed from this corrected film area, assuming an
insoluble monolayer. The aqueous subphase (volume V  74 ml, pH 7.4,
ionic strength 60 mM, 23  1°C) was continuously stirred. Further tech-
nical details are described in our preceding relevant publications, as cited
in the Introduction.
Film preparation and data collection
Our approach requires a fairly large extent of surface activity data under
reasonably stable equilibrium conditions, covering a wider range of spread
lipid and peptide amounts. We found that this could be accomplished in the
least time-consuming manner by recording pressure-area isotherms with
lipid and then successively increasing peptide quantities.
The typical experiment was carried out in the following way. Spreading
was always done over a maximum trough area (of 135 cm2), so that there
was no lateral pressure. Compression was only started after a sufficiently
long waiting period (in the range of 0.5–3 h), to allow the system to
completely stabilize (as monitored by the initial pressure changes in the
course of time). Having reached the end point of compression (usually at
35 mN/m), the monolayer was expanded back to the original maximum
area. After another sufficient waiting period, the next isotherm was re-
corded. With this basic routine a series of isotherms have been recorded,
starting with a given amount of pure lipid, where subsequently more and
more peptide was added. A second isotherm with the initial pure lipid
normally turned out to deviate slightly from the first one. In that case,
however, the third one did reproduce the preceding isotherm, so we
accepted that one as stable. The isotherms with added peptide could always
be reproduced the first time.
Stability
To verify that these isothermic data do correspond sufficiently well to a
stable equilibrium of our monolayer/subphase system, we have compared
them with the results of isochoric measurements. Using troughs of fixed
area, we have spread known amounts of material and waited for a station-
ary state (taking usually 30–60 min). These tests resulted in practically the
same data observed with the isothermic mode but required much more time
to collect a sufficient number of data for the thermodynamic analysis. In
addition, we also tried the isothermic mode with the peptide spread first.
This reversal of the order of spreading made no significant difference
regarding our data (see also Schwarz and Taylor, 1997b). Injection of the
same small amounts of peptide into the subphase tended to give an
extremely slow rate of pressure increase, as already observed in the case of
pure melittin (Wackerbauer et al., 1996). We note that under these circum-
stances the kinetic driving force of partitioning into the lipid monolayer is
virtually nil, because one starts with an extremely small concentration
gradient at the interface.
Mass conservation
Possible adsorption of lipid and/or peptide at the walls of the trough can be
ruled out. The material used by the manufacturer to avoid adhesion is a
special kind of highly condensed ultrapure Teflon with a nonporous,
smooth surface. Experiments involving different accessible wall areas have
indeed not affected our data (Schwarz and Taylor, 1995).
To our knowledge, DMSO is the only practically useful solvent for the
present peptide. To probe its quality to ensure proper spreading, we have
carried out tests in which some pure liquid was also spread on a preformed
monolayer (of pure or mixed surfactant). Then we measured another
isotherm, following our standard routine. After desorption of the added
DMSO into the aqueous subphase, we observed the same isotherm as
before, indicating that this solvent does not drag along lipid or peptide into
the bulk volume. We also refer to our results (see below), which show that
at low pressures all of the spread peptide remains accumulated in the
monolayer.
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RESULTS
In the present experiments the lipid takes the role of an
insoluble first surfactant, whereas the peptide is regarded as
a poorly soluble second surfactant. For a given lateral pres-
sure the increase in surface area, 	A, under equilibrium
conditions was determined from our various series of pres-
sure versus trough area isotherms. Because we have to take
into account here only differences in the area, the Wilhelmy
plate effect cancels out, so it can be ignored.
For a given amount of lipid in the monolayer, nL, we have
plotted 	A*  	A/nL versus n°P. Such experiments were
primarily conducted with nL/nmol  6.22 and 13.35, re-
spectively, comprising a broad range of added peptide
amounts in two independent series of titrations each. Addi-
tional experiments with nL/nmol  4.76 and 9.25, respec-
tively, have been run to confirm the quality of the linear
mass conservation plots. At sufficiently low pressure, all
	A*-n°P plots proved to be well-pronounced straight lines.
Pertinent examples applying to  10 mN/m are presented
in Fig. 1 A. The interpolated n°P values for the individual nL
at the same level of 	A* must be subject to constancy
regarding the interfacial peptide/lipid (“binding”) ratio, r 
nP/nL, and the amount that was partitioned into the sub-
phase, nP
s . Two special cases of the pertinent mass conser-
vation plots according to Eq. 1 are shown in Fig. 1 B. They
are indeed linear and do practically run through the origin
(within a statistical measuring uncertainty of about 0.02
nmol), demonstrating virtually full insertion of the peptide
into the lipid film.
For higher lateral pressures, actual partitioning into the
bulk volume did definitely appear to a greater and greater
extent. Concurrently, the 	A* versus n°P curves become
increasingly bent in the upward direction, as shown by the
example for 25 mN/m exhibited in Fig. 2 A. The linear mass
conservation plots in Fig. 2 B distinctly reveal a substantial
portion of peptide that has entered the aqueous subphase.
This method of processing our data has been executed
with pressures between 1 and 35 mN/m (mostly in steps of
1 mN/m). The range of practically complete “binding” of
peptide by the lipid monolayer reached 15 mN/m. Within
that range the molecular area requirement of the peptide, aP,
can thus be simply derived from a plot of 	A versus n°P, as
illustrated in Fig. 3. The observed linearity reflects a uni-
form value of aP at a given lateral pressure below our upper
limit of 25% peptide per lipid.
FIGURE 1 Data processing at 10 mN/m. (A) Plots of the measured area
increase per lipid (	A* 	A/nL) versus total amount of added peptide, n°P,
for different amounts of lipid in the monolayer: nL/nmol  4.76 (f), 6.22
(F), 9.25 (Œ), and 13.35 (). The crosses on the horizontal dashed line
refer to n°P, nL pairs applying to the same surface and subphase concentra-
tions (see text). (B) Mass conservation plots with n°P, nL pairs at constant
	A*/[cm2/nmol]  2 () and 1 (
), respectively, taken from part A. The
slopes reflect bound peptide/lipid ratios, r 0.234 and 0.117, respectively,
whereas the intercepts (nP
s /nmol  0.027 and 0.013) indicate practically
negligible subphase concentrations.
FIGURE 2 Data processing at 25 mN/m in analogy to Fig. 1. (A) The
apparent upward curvature is due to aggregation of interfacially associated
peptide (see text). (B) The linear mass conservation plots show pronounced
intercepts on the ordinate axis, implying substantial amounts of peptide that
have partitioned into the subphase. 	A*/[cm2/nmol]  1.0 (), 0.8 (
),
and 0.6 (*), respectively.
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For a constant pressure we may now consider A* A°L
	A* (A°L: partial molar area of the pure lipid) as a function
of the interfacial peptide/lipid ratio. Typical examples are
displayed in Fig. 4. They can be examined in view of the
relation
A* AL r  AP (6)
which is readily established from Eq. 5b (AL, AP are the
partial molar areas of the lipid and peptide, respectively.)
We note that for r 3 0, the course of A* can be linearly
extrapolated toward A°L. Nevertheless, the lipid packing
density may change in the vicinity of inserted peptide.
Because such a solvation effect should increase in propor-
tion to r, these area changes would be included in the
apparent value of AP as derived from the slope of the A*-r
plots. Accordingly, the so determined molecular area, aP
( AP/NA, NA: Avogadro’s number), will not necessarily
reflect the true area requirement of the inserted peptide
molecules. At any rate, our measured aP undergoes quite
suddenly a substantial change to a larger value once r
exceeds a critical value rc. This is clearly manifested by the
sharp bend in the plots of A* versus r. The magnitude of rc
decreases markedly upon compression of the monolayer, as
shown by Fig. 5. Below 16 mN/m it appears to fall above
our measuring range of r. The low-r and high-r molecular
areas, aP and aP
Q, respectively, as they depend on pressure,
are presented in Fig. 6.
The partitioning equilibrium of peptide between the lipid
and aqueous moieties is most conveniently described in
terms of the fundamental relationship
r f, cP (7)
which is a possible alternative of Eq. 3b resulting from an
exchange of the variable A* with cP (i.e., the subphase
concentration of the peptide). Because here the bulk volume
was held fixed, we prefer to plot r versus nP
s , the amount of
free peptide (note that an amount of 1 nanomole is equiv-
alent to a subphase concentration of 13.5 nM). Examples of
these “binding” isotherms are exhibited in Fig. 7 for a
number of different lateral pressures.
DISCUSSION
We have presented a novel approach to processing surface
activity data that is suited to determining separately the
molecular area as well as the number of inserted and sub-
phase dissolved molecules of a sparingly soluble surfactant
added to an insoluble monomolecular film of another sur-
factant under equilibrium conditions. This is quite generally
applicable to any such binary mixture in two dimensions,
thus providing highly useful information about pertinent
structural and thermodynamic features in quantitative terms.
In particular, the method can be very well employed to
FIGURE 3 Plots of area increase upon the addition of a total amount of
peptide, n°P, for the examples of a lateral pressure /[mN/m]  5 (f) and
15 (F), respectively. The slopes result in AP/[cm
2/nmol]  9.25 (aP  154
Å2) and 7.45 (aP  124 Å
2), respectively.
FIGURE 4 Monolayer area per lipid (A*  A/nL) plotted versus the
interfacial peptide-to-lipid ratio at various fixed lateral pressures. These are
/[mN/m]  10 (f), 18 (F), and 25 (Œ). The slope of the curves is equal
to the peptide’s apparent partial molar area, AP. Note the sharp bend at
higher pressures, reflecting a substantially larger area requirement of the
inserted peptide above a critical degree of incorporation, rc (indicated by
the dashed arrows).
FIGURE 5 Pressure dependence of the critical peptide/lipid ratio, rc,
indicating a structural transition of inserted peptide aggregates toward a
state of larger area requirement. The solid curve follows an exponential
course.
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investigate the insertion of a peptide (or of any other mem-
brane active agent) in a lipid monolayer, which is consid-
ered a basic model of a biomembrane. The present study
demonstrates the potential of the proposed procedure in the
special case of the putative HIV-1 gp41 fusion peptide
acting on the lipid POPC.
This is, of course, an indirect method of getting access to
the bulk concentration. A more direct measurement of those
extremely small amounts of solute (in the nanomolar range)
is, however, not feasible by standard techniques for a quan-
titative analysis. Even a radioactive tracer assay must be
expected to suffer from a large error margin, as reported
earlier in a monolayer study with a signal peptide (Tamm,
1986).
As far as the kinetics of peptide dissolution into the
subphase is concerned, we would argue that a first step
results in a transfer of peptide to an encounter layer just
below the interfacial film. This may be subject to a rate-
limiting activation energy barrier. A concentration gradient
across the unstirred diffusion layer (which is generally
considered to have a thickness of 103 cm) would then
provide the driving force into the stirred bulk domain. That
gradient will be much larger when the surfactant material is
spread directly on the surface instead of being injected into
the subphase. This would explain the fact that the latter
mode of adding very small amounts of surfactant turns out
to be very much slower in its progress toward equilibrium.
It must be emphasized that the present analysis of exper-
imental data leads to an overall account of the amount of
peptide as it partitions between the interface and the sub-
phase. Accordingly, we can only calculate an average par-
tial molecular area of the interfacial peptide, in case it exists
in different structural states. In any event, this molecular
area may also include a contribution from lipid density
changes or from a possible pressure-induced curvature ef-
fect (Colotto et al., 1996).
Our mass conservation plots under a comparatively low
lateral pressure up to 15 mN/m (see Fig. 1 B) have shown
that practically all of the spread peptide is incorporated into
the lipid film. In such a case of full “binding” we have r 
n°P/nL, so that Eq. 6 predicts a straight line through the origin
for the measured 	A* versus n°P plots (at fixed nL) as long
as the apparent value of AP does not change with increasing
values of r. This is in accordance with our observations (see
Fig. 1 A). The slope would simply be equal to AP/nL. After
all, linearity should always occur in all such plots if a
possible partitioning into the subphase can be described by
a constant coefficient, k, in the relation r  k  nP
s , as it is
applicable to a thermodynamically ideal partitioning pro-
cess. Then the slope will be equal to kAP/(knL  1). Its
reciprocal value plotted versus nL should result in a straight
line whose slope and intercept give access to AP and k.
However, when we turn to the situation in the higher
compression range, our 	A* versus n°P curves exhibit a
pronounced upward bending (see Fig. 2 A). This can also
explain the sigmoidal shape of the measured binding iso-
therms (see Fig. 7). There is an apparent critical value of nP
s
at 0.14 nmol (cP  1.9 nM), which is a typical indication
that large aggregates of solute are being formed in the lipid
solvent. The apparently linear slope beyond that critical
subphase content can be expressed as an ideal partitioning
coefficient of those aggregates with the aqueous peptide
moiety. Naturally that quantity will be reduced upon com-
pression, because the chemical potential of monolayer-in-
serted peptide must increase at higher pressures.
Another sharp bend occurs in the “binding curves” at a
critical peptide/lipid ratio, rc (seen up to 30 mN/m). At
this same ratio, which decreases exponentially upon pres-
sure (see Fig. 5), the A*-r plots also exhibit a sharp bend,
indicating a substantial increase in the peptide’s apparent
molecular area. This could very well reflect a structural
transition of the aggregates that requires much more inter-
facial area.
Beyond 30 mN/m the rc bend can no longer be seen in
the “binding” curves. Instead of this, an upward trend oc-
curs above r  0.12. This concurs with a slight drop in the
FIGURE 6 The peptide’s molecular area as a function of the lateral
compression. The solid points (F) refer to the values, aP, applicable below
rc (the degree of uncertainty is about5 Å
2, as indicated). The open points
(E) in the inset at the upper right represent aP
Q, i.e., the considerably
enhanced area requirements above rc. The dashed line indicates a mean
value of 215 Å2 (standard deviation20 Å2) in the range of 16–30 mN/m.
FIGURE 7 Examples of “binding” curves, i.e., plots of the peptide/lipid
ratio in the monolayer versus the peptide amount in the subphase, nP
s , for
/[mN/m] 18 (F), 25 (Œ), and 32 (). Note the apparent critical amount
of peptide in the subphase at 0.14 nmol.
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high molecular area requirement, possibly because of still
another structural change in the lipid-inserted peptide ag-
gregates. Altogether these features reflect a fairly complex
case of molecular interactions and conversions that we
cannot quantitatively analyze in greater detail at this time.
There are striking changes in the molecular area depend-
ing on compression. Interpretations in terms of structure
may be attempted by sensible geometrical model calcula-
tions. The area requirement per molecule in the low-pres-
sure range (200–130 Å2) varies largely in proportion to
the molecular area of the pure lipid. This may be attributed
to the lateral compressibility experienced by a somewhat
compact arrangement of the peptide when oriented parallel
between the hydrocarbon chains of the lipid. An -helix or
an antiparallel -hairpin seems to be a rather likely structure
in view of the fact that their ideal cross-sectional areas fall
in the proper range, as calculated from atomic structure data
with a molecular modeling program (Taylor and Schwarz,
1997). In contrast to these findings, we had found without
lipid but in the same pressure range a molecular area around
600 Å2, indicating orientation parallel to a pure air/water
interface (Schwarz and Taylor, 1995).
At higher compression, however, there is a clearly pro-
nounced drop toward a quite smaller cross-sectional area. It
suggests a conformation requiring only 100 Å2, presum-
ably parallel -strand configurations, which may be ori-
ented slightly oblique in view of the ideal 80-Å2 self-area in
an orientation normal to the interface (Taylor and Schwarz,
1997). Polymorphism involving a coexistence of -helical
and -strand structures in lipid bilayer membranes at com-
parable pH (but different experimental conditions) has in-
deed been reported in the literature (Gordon et al., 1992;
Martin et al., 1993; Nieva et al., 1994; Pereira et al., 1997).
In addition, an increasing peptide/lipid ratio was shown to
induce an - conversion (Rafalski et al., 1990; Mobley et
al., 1992; Martin et al., 1996). We also note that our inter-
pretation of the observed molecular areas in the higher
compression range is very consistent with some unpub-
lished results obtained in another laboratory (Axelsen, per-
sonal communication). Using the technique of internal re-
flectance infrared spectroscopy (Axelsen et al., 1995)
applied to the same peptide compressed at 20 mN/m in a
supported lipid monolayer (90% POPC, 10% palmitoyl-
oleoylphosphatidylserine (POPS)), the structure could be
shown to be primarily -sheet (with possibly some random
and helical remains). An almost entirely -sheet conforma-
tion was found for a slightly shortened 19mer peptide ana-
log (in 100% POPC).
The rather dramatic increase in the apparent molecular
area to some 215 Å2 derived from the steeper slope in our
A* versus r plots beyond rc (see Fig. 4) can hardly be
explained by changes in the peptide’s self-area alone. A
hairpin-like antiparallel insertion would not allow intermo-
lecular hydrogen bonding for aggregation. On the other
hand, curvature effects as observed with bilayers (Colotto et
al., 1996) would lead to an apparent decrease in area. We
may conclude that the interfacial aggregates undergo a
conversion into larger entities that somehow destabilize the
lipid monolayer. This could be provoked by forming water-
filled structural defects (“pores”) in the lipid monolayer,
possibly as -barrels (Sansom and Kerr, 1995; Marsh,
1996b; 1997). Such an idea is in line with reports on
destabilization and permeabilization of charged and un-
charged lipid vesicle bilayers being caused by the same
HIV-1 fusion peptide (Rafalski et al., 1990; Mobley et al.,
1992; Pereira et al., 1995, 1997). The ratio, , of pore area
per monomer (including the aqueous lumen) over the pep-
tide’s actual molecular area may be calculated by means of
a simple “barrel stave” model. With m cylindrical peptide
monomers of cross-sectional radius RF in the perimeter, one
obtains
    tg/m1 1 2/m/2,
Ro sin/m1 1  RF (8, 9)
where Ro is the inner pore radius. In our case of   2, this
requires 15 monomers for the average pore aggregate.
With RF  5.6 Å (for a self-area of 100 Å
2), we estimate an
inner pore diameter of 4–5 nm. This agrees very well with
the results of the already cited patch-clamp and fluorescence
studies regarding the influenza virus case (Spruce et al.,
1989; Tse et al., 1993). Its fusion peptide was also shown to
induce area expansion and permeation when acting on lipid
vesicles (Longo et al., 1997). For the latter virus it is
actually known that several fusion proteins must interact in
a fusion event, so that the formation of a pore involves
larger aggregates of fusion peptide monomers (Ellens et al.,
1990; Blumenthal et al., 1996). The virus can easily achieve
this because the surface density of the fusion protein in the
viral envelope is very high (Burger et al., 1991). Our present
study suggests that the same holds true in the HIV-1 case.
Another possible explanation for the observed sudden
increase in molecular peptide area could be a phase sepa-
ration in the monolayer, resulting in lipid domains with
some remaining peptide and pure peptide domains, in which
the molecules tend to take on a more tilted orientation, as
they do in a monolayer without lipid (Schwarz and Taylor,
1995). Whatever the underlying structural conversion is, it
may play a significant role in the infection pathway of the
AIDS virus. We expect that the existing alternatives can be
narrowed down by supplementary work applying modern
spectroscopic and/or microscopic techniques.
CONCLUSIONS
The molecular area and the insertion ratio of a strongly
membrane active peptide in a lipid monolayer can be de-
termined separately as a function of the lateral pressure by
means of a novel approach utilizing conventional surface
activity data under equilibrium conditions. This was dem-
onstrated with the HIV-1 gp41 fusion peptide and the bio-
membrane lipid POPC.
In a lower compression range (below 15 mN/m) the
data reveal an apparent -helical or -hairpin conformation
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of the peptide molecule, somehow oriented normal to the
monolayer. Furthermore, practically no partitioning into the
aqueous subphase takes place.
At higher compression (reaching into the lipid packing
density of biomembranes) structural transitions toward
more extended, presumably -strand conformations are ob-
served together with aggregation and appreciable subphase
partitioning. Beyond a critical peptide/lipid ratio in the
monolayer (that decreases upon compression), our results
point to a structural transition of the peptide aggregates,
possibly into water-filled pores or, alternatively, a peptide-
and pressure-induced phase separation of the binary
monolayer.
APPENDIX
Our theoretical foundation was only briefly presented in the main text. In
view of its basic significance, a somewhat more detailed argumentation
may be appropriate. We consider a system consisting of three independent
material components whose total molar amounts are to be denoted ni (i 
0, 1, 2). These components may interact with themselves and/or others to
form all kinds of specific molecular structures, such as different confor-
mations, aggregates, and complexes. A final equilibrium will nevertheless
depend only on the given ni and additional relevant variables of state (e.g.,
temperature, T, and external pressure, p). These variables do then control
all thermodynamic properties of the whole system. In particular, this
applies to the Gibbs free energy, G. Regarding any possible change of the
equilibrium at constant T, p, where in addition to volume work some
further reversible work dw has to be done, the change in G can generally
be described by its total differential:
dGodno1dn12dn2 dw (A1a)
which defines the respective chemical potentials, i, as the pertinent partial
derivatives of G. When dealing with a closed system (allowing no ex-
change of material with the surroundings, so that dni 0) where dw is kept
equal to zero, the condition of equilibrium will accordingly be
dG 0 (A1b)
indicating that G has reached a minimum under the circumstances.
In an interfacial monolayer (phase ) we have dw  dA, so that the
area, A, is to be introduced as an additional independent variable of state
and the interfacial tension is  	G/	A. Because second partial derivatives
must be equal independently of the order of differentiation, we have, for
instance,
	1/	no 	o/	n1 (A2)
Accordingly, it follows that 1 does not depend on no, provided that o can
be shown to be independent of n1.
Turning now to a three-dimensional bulk solution (phase s) with a
volume V, its change in G can be expressed analogously to Eq. A1a with
dw  0 (assuming no reversible work is done in addition to volume work,
pdV). The appropriate chemical potentials can be easily formulated
according to convention when the solute amounts n1, n2 are extremely
small in comparison with that of solvent, no. First of all, we have
o*o RT ln xo*o RTx1 x2 (A3)
where *o is the chemical potential of the pure solvent and the x are the
respective molar fractions. Those of the solute would be on the order of
1010 in our case (nanomole amounts of surfactant versus some 10 mol of
water!). Their effect on o can thus be absolutely neglected. In other
words, we have in the subphase o  *o, which naturally does not depend
on the amounts of added surfactant. These components nevertheless have
a chemical potential of their own, namely,
ii
 RT ln ci i 1, 2 (A4)
where i
 is the conventional standard potential at “infinite” dilution, and
ci  ni/V is the molar concentration.
In the event of a system that combines the interfacial monolayer and its
subphase, the two individual dG according to Eq. A1a must be taken
together. If there is only an exchange of material between the two phases
and A is held constant, this leads to
dG dG  dGS 
i
i
i
sdni
 0 (A5)
which takes into account dni
(s)  dni
() (because of mass conservation)
and the condition of an equilibrium in the whole system according to Eq.
A1b. Therefore the chemical potentials of its individual components must
have assumed equal values everywhere.
In particular, o
() (applying to interfacial water) will be fixed to *o. By
virtue of Eq. A2 we conclude that 1 as well as (analogously) 2 and  do
only depend on n1, n2, and A. Because  and  (or, optionally, ) are
intensive functions of state, they must remain invariant if each of those
extensive variables is multiplied by the same factor (e.g., 1/n1). This
implies that only their ratios are relevant independent variables, for in-
stance, r  n2/n1 and A*  A/n1. Generally it follows from such reasoning
that any intensive function of the whole system can be established as a
function of these two variables. They may be exchanged, however, with
another possible choice through functional inversion, e.g., with , A* or
, c2.
Possible internal equilibria never lead to more independent variables.
As an example, let us assume that surfactant 2 occurs in two different
states, a and b. According to the equilibrium condition and mass conser-
vation, we then have the two equations
ara, rb, bra, rb, ; r ra rb (A6a,b)
which can be used to express ra and rb as a function of r, . By an
analogous combination of pertinent mass action and mass balance laws,
one can always reduce a possible multitude of specific concentration
variables to the given minimum set provided by the total amounts of
independent components.
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